CN1507362A - 利用雾化的胰岛素预防ⅱ型糖尿病的方法 - Google Patents

利用雾化的胰岛素预防ⅱ型糖尿病的方法 Download PDF

Info

Publication number
CN1507362A
CN1507362A CNA028093747A CN02809374A CN1507362A CN 1507362 A CN1507362 A CN 1507362A CN A028093747 A CNA028093747 A CN A028093747A CN 02809374 A CN02809374 A CN 02809374A CN 1507362 A CN1507362 A CN 1507362A
Authority
CN
China
Prior art keywords
insulin
diabetes
type
patient
induction type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028093747A
Other languages
English (en)
Chinese (zh)
Inventor
���ס�S������˹��
艾伦·S·克拉斯纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of CN1507362A publication Critical patent/CN1507362A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CNA028093747A 2001-05-04 2002-04-08 利用雾化的胰岛素预防ⅱ型糖尿病的方法 Pending CN1507362A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28873201P 2001-05-04 2001-05-04
US60/288,732 2001-05-04

Publications (1)

Publication Number Publication Date
CN1507362A true CN1507362A (zh) 2004-06-23

Family

ID=23108398

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028093747A Pending CN1507362A (zh) 2001-05-04 2002-04-08 利用雾化的胰岛素预防ⅱ型糖尿病的方法

Country Status (11)

Country Link
US (1) US20020164267A1 (enExample)
EP (1) EP1387713A1 (enExample)
JP (1) JP2004533438A (enExample)
KR (1) KR20030094377A (enExample)
CN (1) CN1507362A (enExample)
CA (1) CA2445944A1 (enExample)
HU (1) HUP0400083A2 (enExample)
IL (1) IL158192A0 (enExample)
PL (1) PL366398A1 (enExample)
WO (1) WO2002089916A1 (enExample)
ZA (1) ZA200307564B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303036A1 (en) * 2002-12-13 2004-07-09 Pfizer Products Inc. Method of decreasing hepatic glucose output in diabetic patients
JP2009533652A (ja) * 2006-02-21 2009-09-17 グラクソ グループ リミテッド 化学特異的スペクトル解析の方法及びシステム
EP2060268A1 (en) * 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmaceutical compositions for pulmonary or nasal delivery of peptides
EP3793568A4 (en) * 2018-05-14 2022-01-19 Aerami Therapeutics, Inc. INSULIN FORMULATIONS FOR RECONSTITUTION INTO HIGH CONCENTRATION LIQUID SOLUTIONS

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5873358A (en) * 1993-01-29 1999-02-23 Aradigm Corporation Method of maintaining a diabetic patient's blood glucose level in a desired range
US6024090A (en) * 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US5915378A (en) * 1993-01-29 1999-06-29 Aradigm Corporation Creating an aerosolized formulation of insulin
US5970973A (en) * 1993-01-29 1999-10-26 Aradigm Corporation Method of delivering insulin lispro
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5743250A (en) * 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
US5830853A (en) * 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6258341B1 (en) * 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
US5891288A (en) * 1997-09-23 1999-04-06 Proulx Manufacturing, Inc. Process for forming double-strand edged monofilament line for use in line trimmers
ZA989744B (en) * 1997-10-31 2000-04-26 Lilly Co Eli Method for administering acylated insulin.
WO2000016782A1 (en) * 1998-09-18 2000-03-30 The University Of British Columbia Pharmaceutical compositions of vanadium biguanide complexes and their use
US6187291B1 (en) * 1998-09-28 2001-02-13 Robert Weinstein Method and device for facilitating combined aerosol and oral treatments for diabetes mellitus
ATE368037T1 (de) * 1999-04-28 2007-08-15 Sanofi Aventis Deutschland Di-aryl-säurederivate als ppar rezeptor liganden
US6447750B1 (en) * 2000-05-01 2002-09-10 Aeropharm Technology Incorporated Medicinal aerosol formulation
US6620821B2 (en) * 2000-06-15 2003-09-16 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
US20020147134A1 (en) * 2001-04-06 2002-10-10 Geho W. Blair Method of preventing and treating the complications of insulin dependent diabetes mellitus
US6447751B1 (en) * 2001-04-18 2002-09-10 Robert E. Weinstein Method and device for facilitating combined aerosol and oral treatments for diabetes mellitus
MXPA03000966A (es) * 2002-02-28 2003-09-04 Pfizer Prod Inc Agentes antidiabeticos.

Also Published As

Publication number Publication date
CA2445944A1 (en) 2002-11-14
EP1387713A1 (en) 2004-02-11
PL366398A1 (en) 2005-01-24
ZA200307564B (en) 2004-09-29
IL158192A0 (en) 2004-03-28
KR20030094377A (ko) 2003-12-11
JP2004533438A (ja) 2004-11-04
US20020164267A1 (en) 2002-11-07
HUP0400083A2 (hu) 2004-04-28
WO2002089916A1 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
KR100419037B1 (ko) 폐를통한인슐린의전달방법및그조성물
JP2548056B2 (ja) Ｉ型糖尿病に係る自己免疫疾患の抑制および予防用製剤
AU2003238862B9 (en) Formulations for amylin agonist peptides
AU702898B2 (en) Powder formulations containing melezitose as a diluent
KR101736502B1 (ko) Ｇｌｐ-1에 의한 유해 효과의 예방 방법
US7192919B2 (en) Sustained release compositions for delivery of pharmaceutical proteins
JP5813323B2 (ja) 活性薬剤の送達方法
KR20010073033A (ko) 인슐리노트로픽 펩티드의 투여 방법
CN114949183A (zh) 一种替尔泊肽粉雾剂及其制备方法
EP2036572A1 (en) Process for drying a protein, a protein particle and a pharmaceutical composition comprising the protein particle
CN1507362A (zh) 利用雾化的胰岛素预防ⅱ型糖尿病的方法
US20050220722A1 (en) Method of decreasing fasting sugars and weight gains in diabetic patients
HK1062277A (en) Method of preventing type 2 diabetes with aerosolized insulin
US20040112376A1 (en) Method of inducing euglycemia in diabetic patients
AU2002253447A1 (en) Method of preventing type 2 diabetes with aerosolized insulin
AU2006203457A1 (en) Method of decreasing fasting sugars and weight gains in diabetic patients
MXPA00006644A (en) Method for administering monomeric insulin analogs
MXPA00006645A (en) Method for administering aspb28-human insulin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1062277

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1062277

Country of ref document: HK